Exelixis EXEL Change in Other Assets
Change in Other Assets at other companies
Other financials
Where this comes from
Reported directly by Exelixis in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets.
The official record: Exelixis’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Exelixis's change in other assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Exelixis's change in other assets?
- Exelixis (EXEL) reported change in other assets of -$58.65M in Q1 2026.
- How has Exelixis's change in other assets changed year-over-year?
- Exelixis's change in other assets decreased by 188.6% year-over-year, from -$20.32M to -$58.65M.
- What does change in other assets mean?
- The net change in miscellaneous assets like prepayments that impact cash flow.
- How do you interpret change in other assets?
- An increase represents a cash outflow, potentially indicating higher prepayments or deferred costs, while a decrease represents a cash inflow as these assets are consumed or realized.
- How does change in other assets compare across companies?
- Commonly reported by biopharma firms as part of working capital adjustments; peers often show variability based on clinical trial prepayments.